MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Genetics"

  • 2019 International Congress

    Novel familial HPCA mutation associated with autosomal recessive dystonia: Strengthening the role of HPCA in hereditary movement disorders.

    S. Siegert, W. Schmidt, R. Bittner, S. Gobara, M. Freilinger (Vienna, Austria)

    Objective: The objective was to describe the genetic and clinical findings in a Turkish girl, her father and paternal uncle carrying a novel homozygous HPCA…
  • 2019 International Congress

    Update from the international MDSGene initiative: International team science to perform genotype-phenotype correlations for hereditary movement disorders

    S. Petkovic, S. Schaake, J. Huang, H. Madoev, A. Rasheed, K. Lohmann, C. Klein, C. Marras (Luebeck, Germany)

    Objective: The international MDSGene initiative aims to extract, summarize, curate, and illustrate data from movement disorder patients on the phenotypic and mutational level for which…
  • 2019 International Congress

    A hexanucleotide repeat within a SINE-VNTR-Alu retrotransposon inserted in TAF1 modifies expressivity of X-linked dystonia-parkinsonism

    A. Westenberger, C. Reyes, G. Saranza, V. Dobricic, H. Hanssen, A. Domingo, B-H. Laabs, A. Rakovic, P. Bauer, A. Rolfs, A. Münchau, L. Ozelius, R.. Jamora, R. Rosales, C. Diesta, K. Lohmann, I. König, N. Brüggemann, C. Klein (Kalakhang Maynila, Philippines)

    Objective: To investigate the role of a hexanucleotide repeat within a SINE-VNTR-Alu (SVA) retrotransposon insertion in the TAF1 gene in modifying expressivity of X-linked dystonia-parkinsonism…
  • 2019 International Congress

    Two heterozygous SNYE1 mutations presenting as spasmodic adductor dysphonia, task-specific jaw dystonia, generalized dystonia, and ataxia in a Jamaican man

    E. Feinstein, P. Surathi (Newark, NJ, USA)

    Objective: Expanding the phenotype of SYNE1 mutations to include dystonia with ataxia. Background: In 2007 mutations in the SYNE1 gene were found to cause a…
  • 2019 International Congress

    Phenotypic variability and extreme age of presentation of GCH1 gene mutation in dopa-responsive dystonia

    F. Abu Ahmad, P. Ponger, M. Rotstein, A. Migirov Sandrovitz, N. Giladi, A. Orr-Urtreger, T. Gurevich, S. Ben-Shachar (Tel Aviv, Israel)

    Objective: To highlight the wide phenotypical variability among GCH1 gene mutation carriers and the importance of molecular work-up and establishing genotype-phenotype correlations in GCH1 related…
  • 2019 International Congress

    Biallelic ZNF142-null mutations in patients with early-onset generalized dystonia

    M. Zech, M. Skorvanek, V. Han, P. Dosekova, Z. Gdovinova, M. Wagner, R. Berutti, T. Strom, P. Havránková, A. Fečíková, F. Laccone, R. Jech, J. Winkelmann (Munich, Germany)

    Objective: To identify a novel genetic factor contributing to the phenotypic expression of early-onset generalized dystonia. Background: To date, only about 20-30% of cases with…
  • 2019 International Congress

    TPK1 mutation induced childhood onset dystonia and dyskinesia

    L. Au, A. Chan, C. Lau, V. Mok (Hong Kong, Hong Kong)

    Objective: To describe the clinical manifestation of a patient with TPK1 mutation. Background: A number of defects in thiamine metabolism are reported to cause various childhood…
  • 2019 International Congress

    Prospective Characterization of Genetically Confirmed X-linked Dystonia Parkinsonism Patients and their Families: A 1 year longitudinal feasibility study

    P. Acuna, J. de Guzman, N. Ganza-Bautista, J. Lagarde, C. Go, N. Sharma (Boston, MA, USA)

    Objective: A one year feasibility study for a planned prospective longitudinal study of X-linked Dystonia-Parkinsonism patients and their families in rural Philippines. Background: X-linked dystonia…
  • 2019 International Congress

    Assessment, identification and classification of movement disorders in 22q11.2 deletion syndrome

    W. Fung, A. Cunningham, T. Massey, J. Hall, M. Owen, M. Van-Den-Bree, K. Peall (Newport, United Kingdom)

    Objective: To assess the nature and frequency of movement disorders in children with molecularly confirmed 22q11.2 Deletion Syndrome. Background: 22q11.2 Deletion Syndrome (22q11.2DS) is a…
  • 2019 International Congress

    Is the gene expression of TAF1 modified by the X-linked dystonia-parkinsonism-associated hexanucleotide repeat?

    K. Grütz, S. Schaake, B. Laabs, CJ. Reyes, U. Walter, D. Dressler, RD. Jamora, RL. Rosales, N. Brüggemann, K. Lohmann, IR. König, C. Klein, A. Westenberger (Lübeck, Germany)

    Objective: To investigate the impact of the hexanucleotide repeat within the X-linked dystonia-parkinsonism-associated haplotype on endogenous TAF1expression. Background: X-linked dystonia-parkinsonism (XDP) is a severe neurodegenerative movement…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 29
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley